Condition: Childhood-onset Systemic Lupus Erythematous · ANCA-Associated Vasculitis (AAV) · Juvenile Myasthenia Gravis · Sponsor: Cartesian Therapeutics
Safety, tolerability and efficacy of Descarte-08 in children, adolescents and young adults with childhood-onset systemic lupus erythematosus, ANCA-associated vasculitis, juvenile myasthenia gravis, and juvenile dermatomyositis
This description comes directly from the study's public registry record.
Cartesian Clinical Trials · 617-231-8102 · trials@cartesiantx.com
Always discuss trial participation with your own doctor first.
| H01- Children's National Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| H03- Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07089121